Mark Manfredi
Founder bei IKENA ONCOLOGY, INC.
Vermögen: - $ am 31.03.2024
Profil
Mark Manfredi is the founder of Ikena Oncology, Inc. (founded in 2016) where he holds the title of President, Chief Executive Officer & Director.
He is currently the President of Amplify Medicines, Inc. and an Advisor at Atlas Venture Advisors, Inc. Dr. Manfredi previously worked as the Chief Scientific Officer at Raze Therapeutics, Inc. from 2015 to 2016 and as a Vice President-Oncology at Takeda Pharmaceutical Co., Ltd.
Dr. Manfredi completed his undergraduate degree at the University of Rhode Island and his doctorate degree at Boston College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IKENA ONCOLOGY, INC.
-.--% | 01.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Mark Manfredi
| Unternehmen | Position | Beginn |
|---|---|---|
| IKENA ONCOLOGY, INC. | Founder | 01.02.2016 |
Amplify Medicines, Inc.
 Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The private company is based in Boston, MA. The company was founded by Peter Smith. | President | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
Ehemalige bekannte Positionen von Mark Manfredi
| Unternehmen | Position | Ende |
|---|---|---|
Raze Therapeutics, Inc.
 Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.04.2016 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Ausbildung von Mark Manfredi
| University of Rhode Island | Undergraduate Degree |
| Boston College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Amplify Medicines, Inc.
Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The private company is based in Boston, MA. The company was founded by Peter Smith. | Health Technology |
